Inside the COVID-19 Vaccine Clinical Trials

Employer Strategies to Return to Work Safely

Scripta co-founder and Chief Medical Officer Paul Bradley, MD, has been one of the key players in the path to market for the critical, life-saving COVID-19 vaccines. In addition to treating his own patients on the frontline of this pandemic, he has led the Moderna, Pfizer and Novavax COVID-19 vaccine clinical trials as Principal Investigator at Meridian Clinical Research's Internal Medicine site in Savannah, GA.
 

Over the last year, Dr. Bradley has dosed more than 1,000 patients across these clinical trials, dosing the first patient in Moderna's Phase 3 trial with much fanfare. He has worked closely with government agencies and the Operation Warp Speed team, and his own COVID-19 vaccination was even documented by major news networks.
 

Dr. Bradley sat down recently with our CEO Eric Levin to talk about the history-making journey to COVID-19 vaccine emergency authorization, talk vaccine safety, efficacy & rollout, and offer employers strategies for returning to the workplace safely.

We hope this complimentary educational video series helps as you formulate your vaccine strategy and plan for return to work. We'll continue to update our video library with the most current information & insights as things unfold.

COVID-19 VACCINE EMPLOYER RESOURCES

About Scripta & Dr. Paul Bradley

COVID-19: Fact vs. Fiction

1.png
2.png
3.png
4.png
ACCESS OUR FREE COVID-19 VACCINE VIDEO LIBRARY
 

Interested in saving on Rx?

Give us 15 mins and take control of your pharmacy benefit spend.

Scripta_Insights_Logo_White.png

40 Grove St, Suite 270 Wellesley, MA 02482

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle

CUSTOMER SUPPORT:

© Copyright 2020 Scripta Insights, Inc. 

Scripta™ is neither a pharmacy nor a doctor. The benefit service does not tell you what drug to take and does not participate in the drug selection process. Only your physician can determine the medications that are right for you. These alternative medications are options for less costly drugs that physicians may prescribe in place of the medications you are taking now. Scripta has reviewed your current medications only for the purpose of identifying potential cost savings for you to consider with your physician. Scripta has not analyzed the effectiveness or other therapeutic aspects of these medication alternatives. Accordingly, this report and any other forms of communication received from Scripta are not, nor should they be interpreted as, any form of treatment, drug regimen review, or provision of counseling or consultation by a prescriber, pharmacist or pharmacy. Do not stop taking your medication, change your medication, or start taking a new medication without being directed to do so by your physician and filling the prescription under the oversight of a licensed pharmacist. The alternatives set forth above may not be equivalent to your current medication, may interact adversely with your other medications, may not be indicated in light of your other conditions, may cause different or severe side effects, or may be less effective at treating your condition. Medication prices are approximate based on information provided by your pharmacy benefits manager, insurance plans, and/or employer, and may vary from pharmacy to pharmacy. Check with your insurance plan to obtain a full list of pharmacies where your prescriptions can be filled. All information herein is HIPAA protected, treated as highly confidential, and never shared with your employer.

Scripta™, Scripta Insights™ and The Best Meds at the Best Price® are registered trademarks of Scripta Insights, Inc. The contents of the site are for informational purposes only and not intended as a substitute for professional medical advice, diagnosis, or treatment. We do not recommend or endorse any specific prescription drug or pharmacy that may be mentioned herein. Reliance on any information provided by us, our affiliates, employees or others is solely at your own risk.